CervoMed Revenue and Competitors
Estimated Revenue & Valuation
- CervoMed's estimated annual revenue is currently $4.2M per year.
- CervoMed's estimated revenue per employee is $201,000
Employee Data
- CervoMed has 21 Employees.
- CervoMed grew their employee count by 17% last year.
CervoMed's People
Name | Title | Email/Phone |
---|---|---|
1 | VP Finance | Reveal Email/Phone |
CervoMed Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $413.3M | 340 | 0% | $634M | N/A |
#2 | $57.9M | 288 | 0% | N/A | N/A |
#3 | $2M | 10 | -17% | N/A | N/A |
#4 | $33.6M | 167 | 20% | N/A | N/A |
#5 | $15.5M | 77 | 126% | N/A | N/A |
#6 | $25.1M | 125 | 8% | $113M | N/A |
#7 | $0.3M | 3 | 0% | N/A | N/A |
#8 | $10.1M | 50 | -2% | N/A | N/A |
#9 | $1.8M | 385 | -4% | $538M | N/A |
#10 | $46.6M | 232 | -7% | N/A | N/A |
What Is CervoMed?
CervoMed is a public, Boston, MA-based company advancing CNS-focused therapeutics to benefit patients with neurodegenerative diseases. CervoMed was launched in 2014 as EIP Pharma, Inc, by R&D executives from the pharmaceutical and biotech industry. \n\nIn August, 2023 EIP Pharma merged with Diffusion Pharmaceuticals, retaining EIP’s development pipeline, but changing their name to CervoMed (CRVO). \n\nFor more information about the company and updates, please visit www.cervomed.com/ or follow us on Twitter at @Cervo_Med.
keywords:N/AN/A
Total Funding
21
Number of Employees
$4.2M
Revenue (est)
17%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.5M | 21 | -22% | $5M |
#2 | $1.5M | 21 | 5% | $2M |
#3 | $2.1M | 21 | N/A | N/A |
#4 | $2.2M | 21 | 5% | $4.9M |
#5 | $2.1M | 21 | N/A | N/A |